| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 727 | 2.948 | 9.130 | 20.457 | 36.870 | 35.223 | 128.864 |
| Total Income - EUR | - | - | - | 727 | 3.467 | 14.183 | 20.457 | 36.870 | 35.223 | 128.865 |
| Total Expenses - EUR | - | - | - | 1.253 | 5.431 | 10.980 | 16.397 | 12.238 | 25.215 | 46.729 |
| Gross Profit/Loss - EUR | - | - | - | -526 | -1.964 | 3.203 | 4.060 | 24.632 | 10.008 | 82.136 |
| Net Profit/Loss - EUR | - | - | - | -542 | -1.994 | 3.112 | 3.727 | 23.678 | 9.656 | 78.270 |
| Employees | - | - | - | 1 | 1 | 2 | 2 | 2 | 1 | 3 |
Check the financial reports for the company - Evaderm Health S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 1.785 | 4.199 | 4.212 | 5.287 | 6.647 |
| Current Assets | - | - | - | 51 | 7.103 | 2.230 | 1.267 | 20.228 | 9.951 | 76.405 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 1.159 | 0 | 752 |
| Receivables | - | - | - | 0 | 5.655 | 446 | 0 | 0 | 470 | 54.166 |
| Cash | - | - | - | 51 | 1.448 | 1.784 | 1.267 | 19.069 | 9.481 | 21.488 |
| Shareholders Funds | - | - | - | -499 | -2.483 | 676 | 4.388 | 23.726 | 9.705 | 78.318 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 550 | 4.415 | 3.339 | 1.078 | 714 | 5.534 | 4.734 |
| Income in Advance | - | - | - | 0 | 5.170 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Evaderm Health S.r.l.